Clinicians discuss the rapidly evolving therapies, technology, and surgical approaches for early-stage NSCLC and take a fresh look at the future of care. Teamwork: A Multidisciplinary Approach to ...

Vertex and CRISPR Therapeutics have won the backing of NICE for their gene-editing therapy Casgevy as a treatment for the blood disorder beta thalassaemia, a few months after turning it down for ...

The speech-language pathology program at Dalhousie University involves three years of full-time study allotted to course work, clinical practica, and a research project or thesis. The program leads to ...

As the MRI with its building sprawl over five acres, a stone’s throw from Borella junction, celebrates its 125th anniversary, Director Dr. Suranga Dolamulla journeys back in time to its humble origins ...